Literature DB >> 18579721

European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis.

Simone Cagnacci1, Laura Gualco, Eugenio Debbia, Gian Carlo Schito, Anna Marchese.   

Abstract

A total of 148 E. coli strains displaying reduced susceptibility to ciprofloxacin (MIC > or = 2 microg/ml) and causing uncomplicated urinary tract infections in eight European countries during 2003 to 2006 were studied. Their phylogenetic groups, biochemical profiles, and antibiotic susceptibilities were determined. Determination of the O:H serotype, pulsed-field gel electrophoresis (PFGE), randomly amplified polymorphic DNA (RAPD) PCR, and multilocus sequence typing provided additional discrimination. The majority (82.4%) of the microorganisms (122/148) carried resistance to two or more additional drugs, with the pattern ciprofloxacin-trimethoprim-sufamethoxazole-tetracycline-ampicillin being the most represented (73 strains out of 148; 49.3%). Extended-spectrum beta-lactamase production was detected in 12/148 strains (8.1%), with CTX-M-15 being the most-common enzyme. Six strains out of the whole collection studied (4.0%) contained a qnrB-like gene. Overall, 55 different PFGE or RAPD PCR profiles could be distinguished, indicating a substantial heterogeneity. However, about one-third (51/148) of the strains belonged to two clonal groups: O15:K52:H1 (phylogenetic group B2, lactose-nonfermenting variant, ciprofloxacin MIC of 16 microg/ml) and O25:H4 sequence type 131 (ST-131) (phylogenetic group D, ciprofloxacin MIC of > or = 32 microg/ml). With the exception of Poland, strains of these two groups were isolated in samples from all participating countries but more frequently in samples from Spain and Italy. In some representative strains of the two main clonal groups, alterations in GyrA and ParC were the basic mechanism of fluoroquinolone resistance. In some members of the O25:H4 ST-131 group, displaying a ciprofloxacin MIC of > 32 microg/ml, additional OmpF loss or pump efflux overexpression was found. In the Mediterranean area, strains belonging to these two clonal groups played a major role in determining the high rate of fluoroquinolone-resistant E. coli strains observed in the community.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579721      PMCID: PMC2519467          DOI: 10.1128/JCM.00640-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.

Authors:  L McGee; L McDougal; J Zhou; B G Spratt; F C Tenover; R George; R Hakenbeck; W Hryniewicz; J C Lefévre; A Tomasz; K P Klugman
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

Review 2.  Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

Authors:  Duarte C Oliveira; Alexander Tomasz; Hermínia de Lencastre
Journal:  Lancet Infect Dis       Date:  2002-03       Impact factor: 25.071

Review 3.  Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes.

Authors:  R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

4.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

5.  Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.

Authors:  H Wang; J L Dzink-Fox; M Chen; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

6.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe.

Authors:  James R Johnson; Adam L Stell; Timothy T O'Bryan; Michael Kuskowski; Bogdan Nowicki; Candice Johnson; Joel N Maslow; Anil Kaul; Justine Kavle; Guillem Prats
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.

Authors:  A R Manges; J R Johnson; B Foxman; T T O'Bryan; K E Fullerton; L W Riley
Journal:  N Engl J Med       Date:  2001-10-04       Impact factor: 91.245

9.  An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project.

Authors:  G Kahlmeter
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

10.  Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.

Authors:  Kurt G Naber; Giancarlo Schito; Henry Botto; Juan Palou; Teresita Mazzei
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096

View more
  58 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  Plasmid-Mediated Quinolone Resistance in Different Diarrheagenic Escherichia coli Pathotypes Responsible for Complicated, Noncomplicated, and Traveler's Diarrhea Cases.

Authors:  Silvia Herrera-León; María Teresa Llorente; Sergio Sánchez
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  Genetic diversity and population structure of Escherichia coli from neighboring small-scale dairy farms.

Authors:  Jesús Andrei Rosales-Castillo; Ma Soledad Vázquez-Garcidueñas; Hugo Alvarez-Hernández; Omar Chassin-Noria; Alba Irene Varela-Murillo; María Guadalupe Zavala-Páramo; Horacio Cano-Camacho; Gerardo Vázquez-Marrufo
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

4.  Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Authors:  Bente Olesen; Flemming Scheutz; Megan Menard; Marianne N Skov; Hans Jørn Kolmos; Michael A Kuskowski; James R Johnson
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

5.  Implementation of Fourier transform infrared spectroscopy for the rapid typing of uropathogenic Escherichia coli.

Authors:  S E Dawson; T Gibreel; N Nicolaou; H AlRabiah; Y Xu; R Goodacre; M Upton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-08       Impact factor: 3.267

6.  High prevalence of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Bamako, Mali.

Authors:  Véronique Duval; Ibrahim Maiga; Aminata Maiga; Thomas Guillard; Lucien Brasme; Dominique Forte; Janick Madoux; Véronique Vernet-Garnier; Christophe De Champs
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

Review 7.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  Extraintestinal Pathogenic and Antimicrobial-Resistant Escherichia coli Contamination of 56 Public Restrooms in the Greater Minneapolis-St. Paul Metropolitan Area.

Authors:  Muhanad Mohamed; Kris Owens; Abby Gajewski; Connie Clabots; Brian Johnston; Paul Thuras; Michael A Kuskowski; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2015-04-24       Impact factor: 4.792

10.  Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain.

Authors:  Aránzazu Valverde; Rafael Cantón; M Pilar Garcillán-Barcia; Angela Novais; Juan Carlos Galán; Andrés Alvarado; Fernando de la Cruz; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.